Bariatric surgery devices refer to the tools and instruments
used by surgeons to perform weight loss surgery on patients who are severely
obese. These devices help in reducing the size of the stomach and/or bypassing
part of the digestive system to promote weight loss.
Bariatric surgery has become increasingly popular as an
effective treatment for obesity and related health problems such as type 2
diabetes, high blood pressure, and sleep apnea. The market for bariatric
surgery devices is growing rapidly, driven by the rising prevalence of obesity
and an increasing number of surgical procedures being performed worldwide.
The most common types of bariatric surgery devices include
staplers, gastric bands, gastric balloons, and surgical instruments. Staplers
are used to create a small pouch in the stomach that restricts the amount of
food a person can consume. Gastric bands are placed around the stomach to
reduce its size, while gastric balloons are inserted into the stomach to create
a feeling of fullness.
In recent years, there has been significant innovation in
the development of bariatric surgery devices. For example, there has been a
shift towards using minimally invasive techniques, which involve smaller
incisions and less pain for patients. This has led to the development of new
surgical instruments that can be used in these procedures.
In addition, there has been an increase in the use of
robotic-assisted surgery for bariatric procedures. This involves the use of
robotic instruments that are controlled by a surgeon to perform precise
movements during surgery. This technology has been shown to improve surgical
outcomes and reduce the risk of complications.
The market for bariatric surgery devices is highly
competitive, with a number of major players vying for market share. Some of the
key companies in this space include Medtronic, Johnson & Johnson, Apollo
Endosurgery, and Olympus Corporation.
There has also been a significant amount of mergers and
acquisitions activity in the bariatric surgery device market in recent years.
For example, in 2019, Apollo Endosurgery acquired the obesity intervention
division of Allergan, which included the LAP-BAND system, a popular gastric
banding device. This acquisition helped to strengthen Apollo Endosurgery's
position in the bariatric surgery device market.
Dynamics of Bariatric Surgery Devices Market
Drivers in Bariatric
Surgery Devices Market
The market for bariatric surgery devices is being driven by
several factors, including the increasing number of cases of obesity worldwide
and subsequent rise in bariatric surgeries. Bariatric surgery has become more
popular over the years, as it is considered to be safer and more effective than
traditional medical approaches. In 2019, there were 252,000 bariatric surgeries
performed in the United States alone, representing a slight increase from the
previous year. This growing number of surgeries is expected to lead to an
increase in demand for associated equipment and devices, driving the growth of
the global market. The use of minimally invasive devices for bariatric surgery
has helped to lower morbidity rates and reduce post-operative trauma, leading
to an increase in the adoption of such devices. The market is also being driven
by technological advancements in stapling, suturing, and vascular sealing
tools. Additionally, the growing incidence rate of obesity in adults and
advancements in robotic technologies are further propelling the market growth.
The National Institute for Health and Care Excellence (NICE) recommends
bariatric surgery for people with diabetes mellitus and suggests earlier
consideration of surgery. These developments are expected to boost market
growth in the coming years. Furthermore, increasing reimbursement coverage and
sponsored bariatric surgeries by the regional governments of developed nations
are also expected to contribute to market growth.
Challenges in
Bariatric Surgery Devices Market
Postoperative Complications of Bariatric Surgery
The minimally invasive approach to bariatric surgery offers
many benefits such as decreased pain, shorter hospital stays, and fewer wound
complications. However, these surgeries come with certain risks such as
internal hernias, gastroesophageal reflux disease (GERD), chronic nausea and
vomiting, severe dumping syndrome, ulcers, malnutrition, and inflammatory bowel
disease. These complications pose a challenge for the bariatric surgery
industry.
Restraint in
Bariatric Surgery Devices Market
Uncertainty in the Regulatory Environment of the Medical
Device Industry
Emerging countries such as India and South Korea are working
to establish regulatory frameworks that distinguish between medical devices and
pharmaceutical devices & instruments. However, due to the lack of a clear
distinction between drugs and devices, the approval process is currently
unstable, resulting in delays. This uncertainty in the regulatory environment
is expected to increase the approval time for surgical instruments, thus
restraining market growth to a certain extent. In addition, the high cost of
surgical devices is a significant restraint on the growth of the bariatric
surgery device market. The introduction of cutting-edge surgical devices and
technological innovation is driving up the cost of equipment, leading to
increased overall healthcare expenses. Expensive equipment maintenance is also
hindering business expansion. However, mounting government funding for R&D
programs for bariatric surgery devices is expected to overcome this constraint.
Ecosystem of Bariatric Surgery Devices Market
The bariatric surgery devices market is segmented into two
categories based on device type, namely minimally invasive surgical devices and
noninvasive surgical devices. During the forecast period, the minimally
invasive surgical devices segment held the largest market share. Laparoscopic
procedures are preferred over open weight loss surgical procedures as they
involve fewer incisions, which are smaller in size and lead to less pain,
faster recovery, and significantly lower complication and mortality rates.
These advantages are expected to boost the market growth of minimally invasive
surgical devices.
The market for bariatric surgery devices is segmented based
on procedure into sleeve gastrectomy, gastric bypass, revision bariatric
surgery, noninvasive bariatric surgery, mini-gastric bypass, adjustable gastric
banding, and biliopancreatic diversion with duodenal switch (BPD/DS). The
sleeve gastrectomy segment accounted for the largest share of the global
market. The increasing popularity of sleeve gastrectomy can be attributed to its
advantages such as safety, effectiveness, affordability, and limited
complications compared to other bariatric procedures. It is a minimally
invasive procedure that involves the removal of a portion of the stomach,
resulting in a smaller stomach size and decreased appetite. Sleeve gastrectomy
is recommended for patients with a body mass index (BMI) of 40 or higher or a
BMI of 30 or higher with at least one obesity-related health condition, such as
diabetes or high blood pressure. The growing prevalence of obesity and related
health conditions is expected to fuel the demand for sleeve gastrectomy and
drive the growth of the bariatric surgery devices market.
In the past, gastric bypass surgeries were performed through
open surgery, which involved making large incisions on the belly. However, with
the introduction of laparoscopic bypass surgeries, conventional methods have
been overtaken. Laparoscopic surgery is performed with small minimal incisions,
making it more convenient for patients. This minimally invasive technique
involves making the stomach into a small pouch, allowing minimal food to pass
into the small intestine. Bypassing the small intestine results in lesser
nutrient and fat absorption, leading to weight loss.
Despite gastric bypass surgeries dominating the bariatric
surgery devices market, it is anticipated that sleeve gastrectomy will be the
fastest-growing market during the forecast period. Sleeve gastrectomy has
recently been approved by the FDA and is an incision-less surgery, which has
led to its rising popularity. In recent years, this procedure has witnessed
several developments. According to the American Society for Metabolic and
Bariatric Surgery (ASMBS), out of 180,000 surgeries performed, sleeve
gastrectomy accounted for the major share (44%) followed by gastric bypass.
Additionally, the Centers for Medicare and Medicaid Services (CMS) has released
the CMS Laparoscopic Sleeve Gastrectomy National Care Determination, which
provides coverage for laparoscopic sleeve gastrectomy (LSG).
Regional Insights
During the forecast period, North America held the largest
share of the bariatric surgery devices market among the five major regions
including Europe, Asia Pacific, Latin America, and the Middle East &
Africa. The region's dominance can be attributed to various factors such as the
high prevalence of chronic diseases, rising rates of obesity and diabetes,
increasing healthcare expenditure, a growing number of bariatric surgeries, and
a rising demand for minimally invasive surgeries. In contrast, Europe is
experiencing a surge in obesity rates with Ireland recording the highest
numbers. The WHO has reported on the European Modelling Obesity Project,
highlighting the healthcare cost burden and interventions required to address
this issue. As a result, governments are funding academic institutions to
develop innovative strategies.
According to recent statistics, the Asia Pacific region is
experiencing the highest growth rate of over 10.5% due to a large obese
population and increased medical tourism with affordable bariatric surgery
options. In Europe, a report by the International Federation for the Surgery of
Obesity and Metabolic Disorders (IFSO) in 2019 showed that there were 152,000
bariatric surgeries conducted in 2018, with sleeve gastrectomy being the most
commonly performed procedure at 58.4% of all surgeries, followed by Roux-en-Y
gastric bypass at 28.1%. In North America, the American Society for Metabolic
and Bariatric Surgery (ASMBS) estimated that 252,000 bariatric surgeries were
performed in the United States in 2019, while in Canada, approximately 12,000
surgeries were conducted in 2018. In South America, limited data is available,
but a 2019 review reported 103,484 bariatric surgeries in Brazil in 2017, with
sleeve gastrectomy being the most common procedure at 59.7%. Bariatric surgery
is less common in Africa, with a total of 4,266 surgeries performed from 2000
to 2019, and sleeve gastrectomy being the most commonly performed procedure at
64.5%. Finally, bariatric surgery is becoming more common in the Asia Pacific
region, with approximately 160,000 surgeries performed in 2018, and sleeve
gastrectomy being the most commonly performed procedure at 71.3%.
Dominating Companies in Bariatric Surgery Devices Market
- JOHNSON & JOHNSON
- MEDTRONIC PLC
- INTUITIVE SURGICAL, INC.
- OLYMPUS CORPORATION
- APOLLO ENDOSURGERY, INC.
- RESHAPE LIFESCIENCES INC.
- SPATZ MEDICAL
- COUSIN BIOTECH
- MEDIFLEX SURGICAL PRODUCTS
- B. BRAUN MELSUNGEN AG
- STANDARD BARIATRICS, INC.
- RICHARD WOLF GMBH
- MEDSIL
- GRENA LTD
- SURGICAL INNOVATIONS GROUP PLC
- A.M.I. GMBH
- REACH SURGICAL
- SILIMED INDUSTRIA DE IMPLANTES LTDA.
- COOK MEDICAL LLC
- SHANGHAI YISI MEDICAL TECHNOLOGY CO., LTD.
- BOWA-ELECTRONIC GMBH & CO. KG
- TROKAMED GMBH
- ASPIRE BARIATRICS, INC.
- VICTOR MEDICAL INSTRUMENTS CO., LTD.
- APPLIED MEDICAL RESOURCES CORPORATION
- Integra Life Sciences Holding Corporation
- CONMED
- Ethicon Inc.
- W. L. Gore & Associates, Inc.
- TransEnterix Inc.
- Allergan Inc.
- Covidien Plc
- GI Dynamics Inc.
- USGI Medical Inc.
- Semiled Ltd.
Recent Developments in Bariatric Surgery Devices Market
- In March 2021, Johnson & Johnson Medical Devices
Companies announced that it had completed the acquisition of Lumenis Ltd.'s surgical
business. Lumenis is a leading manufacturer of laser and energy-based devices
used in minimally invasive surgery, including bariatric procedures.
- In September 2020, Apollo Endosurgery, Inc. announced a
strategic partnership with Distalmotion to commercialize the latter's surgical
robot, named Dexter. This partnership is expected to expand the market for
Apollo's bariatric surgery devices and provide a more efficient and precise
solution for surgeons.
- In November 2019, Medtronic plc announced the acquisition of
Klue, a company that specializes in developing software for automatic
identification and tracking of hand gestures. Medtronic plans to integrate this
technology into its robotic-assisted surgical systems used in bariatric and
other surgeries.
- In May 2019, Boston Scientific Corporation completed the
acquisition of Vertiflex, Inc., a manufacturer of minimally invasive spinal
surgery devices. While this acquisition is not directly related to bariatric
surgery, it represents a trend towards minimally invasive surgical procedures,
which is also relevant for bariatric surgery devices.
- In February 2019, Apollo Endosurgery, Inc. announced a
partnership with Medtronic plc to distribute its products in the United States.
The partnership enables Medtronic to expand its portfolio of bariatric surgery
devices, while Apollo gains access to a broader customer base.
- In 2021, Apollo Endosurgery, a company that develops medical
devices for weight loss, announced a merger with Lpath, a biotechnology
company. The combined company will focus on developing medical devices and
therapies to address obesity and other gastrointestinal disorders.
- In 2019, Medtronic, a leading medical technology company,
acquired Klue, a start-up company that develops wearable technology for
tracking eating behaviors. Medtronic plans to integrate Klue's technology into
its bariatric surgery devices to help patients monitor their food intake and
make healthier choices.
- In 2019, Boston Scientific, a medical technology company,
acquired Vertiflex, a company that develops minimally invasive spinal implants.
While this acquisition was not directly related to bariatric surgery devices,
it demonstrates Boston Scientific's commitment to expanding its portfolio of
minimally invasive medical devices.
- In 2018, Intuitive Surgical, a company that develops
surgical robots, announced a partnership with Johnson & Johnson to develop
a new surgical robot for bariatric surgeries. The robot, which is still in
development, is designed to make bariatric surgeries safer and more effective.
Overall, the market for bariatric surgery devices is
expected to continue to grow in the coming years, driven by the rising
prevalence of obesity and an increasing demand for effective treatments. As new
technologies and devices continue to emerge, the market is likely to become
even more competitive, with companies striving to stay ahead of the curve in
terms of innovation and product development.
Bariatric Surgery Devices Market - Get your Free sample copy of the Report :::::::::::::::>
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.